<DOC>
	<DOCNO>NCT00530413</DOCNO>
	<brief_summary>The purpose study test effectiveness low-dose Phenobarbital treatment catamenial epilepsy . We propose since catamenial seizure associate reduction level GABA-enhancing allopregnanolone , short-term replacement GABAR-enhancing agent Phenobarbital reduce incidence catamenial seizure .</brief_summary>
	<brief_title>Study Phenobarbital Inhibition Catamenial Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Phenobarbital</mesh_term>
	<criteria>Adult female patient seek medical attention seizure Regular menstrual cycle At least 2 seizure per month Must least one form birth control abstinence Must stable anticonvulsant regimen least one exceed three anticonvulsant , use perimenstrual seizure medication hormone preparation If take benzodiazepine therapeutic purpose , must stable regular dose Must willing take least 400mcg folic acid day study Must able detect , count record seizures Can pregnant try become pregnant Can use hormonal birth control method least 3 month prior enrollment Can allergy Phenobarbital Can history nonepileptic seizure Can know liver dysfunction history chronic hepatitis Can history neurological disorder history status epilepticus precede year Can ahve physical psychiatric condition PIs opinion could compromise ability participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>